Data from A Phase I Dose-escalation Study of AZD3965, an Oral Monocarboxylate Transporter 1 Inhibitor, in Patients with Advanced Cancer
Authors:
- Sarah HalfordSHSarah Halford
- Gareth J. VealGareth J. Veal
- Stephen R. WedgeSWStephen R. Wedge
- Geoffrey S. PayneGPGeoffrey S. Payne
- Chris M. BaconCBChris M. Bacon
- Philip SloanPSPhilip Sloan
- Ilaria DragoniIDIlaria Dragoni
- Kathrin HeinzmannKHKathrin Heinzmann
- Sarah PotterSPSarah Potter
- Becky M. SalisburyBSBecky M. Salisbury
- Maxime Chénard-PoirierMCMaxime Chénard-Poirier
- Alastair GreystokeAGAlastair Greystoke
Open Access
- 1 April 2023
- other
- Published by American Association for Cancer Research (AACR)